08 November 2023 – TMC is delighted to announce another successful clinical trial application (CTA) approval across four EU countries using the new EU Clinical Trial Information System (CTIS) on behalf of one of its clients. TMC is a global world-class clinical research organisation dedicated to supporting the progression of life-saving treatment solutions for diseases that are often neglected. We offer full product development lifecycle expertise from pre-clinical through to post-marketing, focused on developing tailored solutions for biopharmaceutical companies. Our experience in CTIS and other regulatory submissions can support companies navigating this challenge.

Contact us to set up a call and find out more.

Published On: 8 November 2023By Categories: News